Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 191 results found. Search for [ moderna vaccine update ]

Results 1 to 21 of 191
BusinessToday.In
February 8, 2021
Coronavirus vaccine: Sarah Gilbert, professor of vaccinology at Oxford told BBC that the researchers have already started working on the first part of the manufacturing process


BusinessToday.In
January 28, 2021
The European Medicines Agency is expected to give its long-awaited approval to AstraZeneca's COVID-19 vaccine on Friday


BusinessToday.In
January 28, 2021
The European Medicines Agency is expected to give its long-awaited approval to AstraZeneca's COVID-19 vaccine on Friday


PB Jayakumar
January 27, 2021
COVID-19 vaccine: About 19 vaccines are going to be globally available in the coming few weeks and months. Of this, about nine have already got emergency use authorisation


PB Jayakumar
January 26, 2021
Both COVID-19 vaccines being administered in India's extensive vaccination programme - Serum-Oxford-AstraZeneca's Covishield and Bharat Biotech's Covaxin - have a very short shelf life of just six months


BusinessToday.In
January 24, 2021
Coronavirus vaccine: Additionally, nine out of the 10 cases occurred in patients with previously known allergies. It is still not clear what caused these reaction


BusinessToday.In
January 11, 2021
Pfizer is yet to submit additional data sought by India authorities regarding its COVID-19 vaccine for granting emergency use approval to it; the company has missed last three SEC meetings too


Joe C Mathew
January 7, 2021
Fact sheets for recipients of Moderna and Pfizer-BioNTech vaccines in US and UK clarify that the vaccines are yet to be fully approved; recipients have been asked to get help if they experience severe side effects or allergic reactions


Reuters
January 5, 2021
Israel has begun to vaccinate its population at one of the quickest rates in the world, and it aims to reach all vulnerable citizens by late January


BusinessToday.In
December 29, 2020
Poonawalla says Covishield shows efficacy level of 95 per cent provided two shots are taken after a gap of 2-3 months; AstraZeneca will make that public with documentation soon, he adds


BusinessToday.In
December 29, 2020
The chief executive of Serum Institute - the biggest vaccine maker in the world by volume - said all trial data for Covishield has been provided to authorities in the UK and India as \"nobody wants to risk safety\"


BusinessToday.In
December 19, 2020
Despite the rise in cases, India's Covid-19 recoveries have witnessed a steep exponential rise -- from 50,000 in May to over 95 lakh in December. Recoveries are more than 30 times active cases, says  HealthMin


Reuters
December 18, 2020
Pfizer said in a statement it had made the application to Japan's Health Ministry, along with providing information on tests it has carried out up to now


BusinessToday.In
December 16, 2020
Pfizer Albert Bourla said that Pfizer runs a lot of polls to see what would make people willing to take the vaccine. Bourla added that one of the top responses is if the CEO takes it


Reuters
December 5, 2020
To date 189 countries have joined the COVAX programme, which is backed by the WHO and seeks to ensure equitable distribution of vaccines


BusinessToday.In
December 5, 2020
DCGI VG Somani has said the CDSCO will facilitate analysis of interim clinical trial data at pre-defined stages. PM Modi says nearly eight vaccine candidates, out of which three are indigenously developed, are undergoing trials in India


PTI
December 5, 2020
Pune-based Serum Institute of India (SII) has collaborated with the University of Oxford and the British-Swedish pharmaceutical company AstraZeneca for making the COVID-19 vaccine, 'Covidshield', and is conducting trials in India


Reuters
December 5, 2020
WHO's top emergency expert Mike Ryan also cautioned against complacency in the wake of vaccine roll-out, adding although they were a major part of the battle against COVID-19, vaccines would not on their own end the pandemic


BusinessToday.In
December 4, 2020
COVID-19 vaccine trial updates: AIIMS director Dr Randeep Guleria has pinned his hopes on the five coronavirus vaccine candidates which are in varying stages of trials across India


BusinessToday.In
December 4, 2020
Study says anti-bodies declined slightly over time but remained elevated in all participants even 3 months after vaccination. NIAID director Anthony Fauci and other infectious diseases experts say it is possible that our bodies would remember virus and produce more anti-bodies if exposed to the virus again


PAGES 1 OF 10  12345